Alina Dudele

Mrs. Alina Dudele

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2025 in Health Policy
Verified
Journal Article
Open access
CNCostase Ndayishimiye
Costase Ndayishimiye
Marzena TamborMarzena Tambor
Marzena Tambor
DBDaiga Behmane
Daiga Behmane
ADAntoniya Dimova
Antoniya Dimova
ADAlina Dudele
Alina Dudele
KDKatarzyna Dubas-Jakóbczyk
Katarzyna Dubas-Jakóbczyk
Health care provider payment schemes consist of a complex set of arrangements used to influence provider behavior towards specific health policy objectives. The study aimed at: 1) providing a structured, comparative overview of current payment schemes within the public health system in selected Central and Eastern European (CEE) countries for different health care providers; 2) identifying and comparing major changes in payment schemes since 2010. Methods included: 1) data collection form development; 2) desk research; 3) national experts' consultations; 4) comparative analysis. The results indicate that the nine CEE countries (Bulgaria, Croatia, Czechia, Estonia, Latvia, Lithuania, Hungary, Poland, and Romania) show numerous similarities in provider payment method mix and in the general direction of the recent changes conducted in this field. Output-based payment methods prevail across all countries and types of providers. Primary health care (PHC) providers are characterized by the most diverse payment method mix. PHC and hospital inpatient care have experienced the most frequent changes in their payment schemes within the last 13 years. These focused mostly on modifying existing payment methods (e.g. detailing payment categories), and applying additional methods to pay for specific services or performance (e.g. fee-for-service, bonus payments). The objectives of conducted change were often similar, thus, there is high potential for a shared, cross-country learning.

12 December 2023 in Research Square
Verified
Preprint
Open access
PDF file
CNCostase Ndayishimiye
Costase Ndayishimiye
Marzena TamborMarzena Tambor
Marzena Tambor
DBDaiga Behmane
Daiga Behmane
ADAntoniya Dimova
Antoniya Dimova
ADAleksandar Džakula
Aleksandar Džakula
KDKatarzyna Dubas-Jakóbczyk
Katarzyna Dubas-Jakóbczyk
Health care provider payment schemes consist of a complex set of arrangements used to influence provider behavior towards specific health policy objectives. The study aimed at: 1) providing a structured, comparative overview of current payment methods in selected Central and Eastern European (CEE) countries for different health care providers; 2) identifying and comparing major changes in payment schemes since 2010. Methods included: 1) development of a theoretical framework and data collection form; 2) desk research; 3) national experts’ consultations; 4) comparative analysis. The results indicate that the nine CEE countries (Bulgaria, Croatia, Czechia, Estonia, Latvia, Lithuania, Hungary, Poland, and Romania) show numerous similarities in provider payment method mix and in the general direction of the changes conducted in this field since 2010. Output-based payment methods prevail across all countries and types of providers. Primary health care (PHC) providers are characterized by the most diverse payment method mix, while both PHC and hospital inpatient care have experienced the most substantial changes in their payment schemes within the last 13 years. The most frequently conducted changes focused on modifying existing payment methods (e.g. detailing payment categories), and applying additional methods to pay for specific services or performance (e.g. fee-for-service, bonus payments). The objectives of conduced change were often similar, thus, there is high potential for a shared, cross-country learning.

21 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
USUgis Sprudzs
Ugis Sprudzs
ADAlina Dudele
Alina Dudele
JPJevgenijs Eugene Proskurins
Jevgenijs Eugene Proskurins
OROskars Radzins
Oskars Radzins
Background and Objectives: Diabetes mellitus (Type 2 diabetes) is a significant and rapidly growing global healthcare challenge and a leading cause of severe complications, including cardiovascular disease (CVD), chronic kidney disease and other conditions. In Latvia more than 103 000 individuals have been registered in the Latvian Diabetes Patient Register, of whom over 90% had type 2 diabetes. Since early diagnosis can reduce complication risk, considerable effort has been devoted to the development of numerous CVD risk prediction tools using traditional statistics as well as data science-based methods. This article augments these efforts with predictive models built specifically for Latvia’s diabetes patient population. Materials and Methods: Models used anonymized diabetes patient data stored at Latvia’s Center for Disease Prevention and Control containing routinely collected information on patients’ utilization of publicly funded healthcare services. No clinical data were included. In keeping with best practices in model development, 96 302 qualifying available patient records were randomly partitioned into a 70% training data portion and 30% for out-of-sample validation. We tested three modeling methodologies – logistic regression, Random Forests, and XGBoost. Results: The binary dependent variable was defined as the occurrence of an ischemic heart disease hospitalization during 2023 or 2024. The predictor variables were limited to data from the prior two year period, 2021-2022. The three model types all produced similar fit to the data – area under the Receiver Operating Curve (ROC) of 0.70-0.71 in the validation data, which is comparable to results obtained in other studies, including SCORE2. Prediction reliability, as measured by the Brier Score, was 0.11. Conclusions: We find ischemic heart disease hospitalization risk prediction models based on routinely collected Latvian health care utilization data to be feasible. Such a model could be applied to identify diabetes patients with an elevated (30%-40%) risk of experiencing an ischemic heart disease-related hospitalization over the next two years. While the actual size of Latvia’s diabetes patient population in the near future is not precisely known, we estimate that this highest risk decile may contain a group of 8 000 – 10 000 diabetes patients. We suggest future prospective studies to evaluate whether integrating the model into primary care can lead to earlier interventions and a reduction in preventable ischemic heart disease hospitalizations.

10 November 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
USUgis Sprudzs
Ugis Sprudzs
ADAlina Dudele
Alina Dudele
JPJevgenijs Eugene Proskurins
Jevgenijs Eugene Proskurins
OROskars Radzins
Oskars Radzins
Background and Objectives: Diabetes mellitus (Type 2 diabetes) is a significant and rapidly growing global healthcare challenge and a leading cause of severe complications, including cardiovascular disease (CVD), chronic kidney disease and other conditions. In Latvia, more than 103 000 individuals have been registered in the Latvian Diabetes Patient Register, of whom over 90% have type 2 diabetes. Since early diagnosis can reduce complication risk, considerable effort has been devoted to the development of numerous CVD risk prediction tools using traditional statistics as well as data science-based methods. This article augments these efforts with predictive models built specifically for Latvia’s diabetes patient population. Materials and Methods: Models used anonymized diabetes patient data stored at Latvia’s Center for Disease Prevention and Control, containing routinely collected information on patients’ utilization of publicly funded healthcare services. No clinical data were included. In keeping with best practices in model development, 96,302 qualifying available patient records were randomly partitioned into a 70% training data portion and 30% for out-of-sample validation. We tested three modeling methodologies—logistic regression, Random Forests, and XGBoost. Results: The binary dependent variable was defined as the occurrence of an ischemic heart disease hospitalization during 2023 or 2024. The predictor variables were limited to data from the prior two-year period, 2021–2022. The three model types all produced similar fit to the data—area under the Receiver Operating Curve (ROC) of 0.69–0.71 in the validation data, which is comparable to results obtained in other studies, including SCORE2. Prediction reliability, as measured by the Brier Score, was 0.11. Conclusions: We find ischemic heart disease hospitalization risk prediction models based on routinely collected Latvian health care utilization data to be feasible. Such a model could be applied to identify diabetes patients with an elevated (30–40%) risk of experiencing an ischemic heart disease-related hospitalization over the next two years. In a retrospective validation cohort, the highest risk decile had an observed two-year hospitalization rate above 30%. An illustrative projection of a similarly sized decile is about 8000–10,000 patients, but this estimate is exploratory. The model is not ready for clinical implementation; prospective studies are required to test calibration, clinical utility, and benefit. We suggest future research to evaluate whether integrating the model into primary care can lead to earlier interventions and a reduction in preventable ischemic heart disease hospitalizations.